# Cefoxitin

## Lofatin inj 2gm

| TAH Drug Code      | [ILFT](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ILFT)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Infections caused by staphylococcus, streptococcus, pneumococcus, meningococcus, and other susceptible bacteria.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Dosing             | [仿單] 2-4g/day, divided into 2-4 doses [UpToDate] Usual adult dosage range: IV 1-2 g every 6-8 hours; pediatric (ages >=3 months) general dosing: IV 80-160 mg/kg/day divided every 4-8 hours; maximum: 12 g/day                                                                                                                                                                                                                                                                                                                                                                               |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Contraindications  | Hypersensitivity to cefoxitin and cephalosporins.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Adverse Effects    | 1% to 10%: Gastrointestinal: Diarrhea <1%: Anaphylaxis, angioedema, bone marrow depression, dyspnea, eosinophilia, exacerbation of myasthenia gravis, exfoliative dermatitis, fever, hemolytic anemia, hypotension, increased blood urea nitrogen, increased serum creatinine, increased serum transaminases, interstitial nephritis, jaundice, leukopenia, nausea, nephrotoxicity (increased; with aminoglycosides), phlebitis, prolonged prothrombin time, pruritus, pseudomembranous colitis, skin rash, thrombocytopenia, thrombophlebitis, toxic epidermal necrolysis, urticaria, vomiting |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| More Info          | [UpToDate](https://www.uptodate.com/contents/cefoxitin-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

